[The Herald] Zimbabwe has 8,000 doses of injectable pre-exposure prophylaxis drug, cabotegravir, for use in the ongoing pilot programme to establish its efficacy in preventing HIV as the country pulls all the stops to completely eradicate all new infections of the virus by 2030.